How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
Ryan Quigley
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Esther Lee Kim, MD
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Deepak Sambhara, MD
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
David Chin Yee, MD, FASRS
It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
David Eichenbaum, MD
Suprachoroidal Steroids in Patients With a History of Glaucoma and Ocular Hypertension
Maria H. Berrocal, MD
Danny Mammo, MD
Diagnosis Delays in Stargardt Disease
Alexis Warren, MD
Jesse Sengillo, MD
Sruthi Arepalli, MD
Elevating Clinical Efficiency
Diana Chu
Redefining The Cash-Pay Model in Modern Optometric Practice
Jason E. Compton, OD, FAAO
Practice Efficiency and Innovation
Jacob Lang
Tailored Treatment in Retinal Disease: Using Biomarkers to Guide Anti-VEGF Therapy
Jennifer Caudle, DO, FACOFP
Michael Javaheri, MD, MSc, FASRS
Strategies for Addressing Complications in Retinal Vein Occlusion
Lisa Schocket, MD
The Evolution of Retinal Vein Occlusion Treatment: From Laser to Anti-VEGF
Evaluating Eyelid Wipes for Dry Eye Disease: Clinical Trial Insights
Houman Hemmati, MD, PhD
Overcoming Barriers in Dry Eye Disease Care: Current and Emerging Options
Defining Chronic Ocular Surface Pain: Causes, Clues, and Complexity
Anat Galor, MD, MSPH
Loading...
We're glad to see you're enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.